Chen SJ - Search Results

1

SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.

Chen BY, Song J, Hu CL, Chen SB, Zhang Q, Xu CH, Wu JC, Hou D, Sun M, Zhang YL, Liu N, Yu PC, Liu P, Zong LJ, Zhang JY, Dai RF, Lan F, Huang QH, Zhang SJ, Nimer SD, Chen Z, Chen SJ, Sun XJ, Wang L. Chen BY, et al. Among authors: chen z, chen sb, chen sj. Blood. 2020 Jun 18;135(25):2271-2285. doi: 10.1182/blood.2019001963. Blood. 2020. PMID: 32202636 Free PMC article.

2

Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk.

Zhu Q, Zhang JW, Zhu HQ, Shen YL, Flexor M, Jia PM, Yu Y, Cai X, Waxman S, Lanotte M, Chen SJ, Chen Z, Tong JH. Zhu Q, et al. Among authors: chen z, chen sj. Blood. 2002 Feb 1;99(3):1014-22. Blood. 2002. PMID: 11807007 Free article.

3

Expanding the use of arsenic trioxide: leukemias and beyond.

Chen Z, Chen GQ, Shen ZX, Sun GL, Tong JH, Wang ZY, Chen SJ. Chen Z, et al. Among authors: chen sj, chen gq. Semin Hematol. 2002 Apr;39(2 Suppl 1):22-6. doi: 10.1053/shem.2002.33611. Semin Hematol. 2002. PMID: 12012319 Review.

4

The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution.

Zhao WL, Xu L, Wu W, Yan H, Tang W, Hu J, Chen Y, Li JM, Zeng XY, Xiong SM, Shen ZX, Chen Z, Wang ZY, Chen SJ. Zhao WL, et al. Among authors: chen z, chen sj, chen y. Hematol J. 2002;3(3):137-44. doi: 10.1038/sj.thj.6200173. Hematol J. 2002. PMID: 12111649

5

[Experimental study of low dose arsenic trioxide in treatment of patients with acute promyelocytic leukemia].

Jia PM, Zhu Q, Yu Y, Chen GQ, Chen SJ, Chen Z, Wang ZY, Tong JH. Jia PM, et al. Among authors: chen z, chen sj, chen gq. Ai Zheng. 2002 Apr;21(4):337-40. Ai Zheng. 2002. PMID: 12452006 Chinese.

6

Treatment of acute promyelocytic leukemia with ATRA and As2O3: a model of molecular target-based cancer therapy.

Fang J, Chen SJ, Tong JH, Wang ZG, Chen GQ, Chen Z. Fang J, et al. Among authors: chen z, chen sj, chen gq. Cancer Biol Ther. 2002 Nov-Dec;1(6):614-20. doi: 10.4161/cbt.308. Cancer Biol Ther. 2002. PMID: 12642682 Review.

7

[In vitro study of the effects of arsenic trioxide combined with 8-CPT-cAMP on differentiation induction in retinoic acid resistant acute promyelocytic leukemia cells].

Zhu Q, Yu Y, Jia PM, Cai X, Chen SJ, Chen Z, Wang ZY, Tong JH. Zhu Q, et al. Among authors: chen z, chen sj. Zhonghua Xue Ye Xue Za Zhi. 2003 Jan;24(1):6-9. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12679001 Chinese.

8

[Clinical observation of the short-term efficacy of the treatment with combination of all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in newly diagnosed acute promyelocytic leukemia (APL)].

Liu YF, Shen ZX, Chen X, Wang AH, Cao Q, Zhu YM, Chen SJ, Chen Z, Wang ZY. Liu YF, et al. Among authors: chen z, chen sj, chen x. Zhonghua Xue Ye Xue Za Zhi. 2003 Jan;24(1):25-7. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12679006 Chinese.

9

[Establishment of transgenic mice for HRX-EEN fusion gene].

Sun YP, Xiong H, Wang Y, Wang L, Huang QH, Zhang QH, Kong H, Zhang LJ, Chen SJ, Chen Z, Wang ZG, Lu ZY. Sun YP, et al. Among authors: chen z, chen sj. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Dec;20(6):522-7. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003. PMID: 14669223 Chinese.

10

Functional contribution of EEN to leukemogenic transformation by MLL-EEN fusion protein.

Liu H, Chen B, Xiong H, Huang QH, Zhang QH, Wang ZG, Li BL, Chen Z, Chen SJ. Liu H, et al. Among authors: chen z, chen b, chen sj. Oncogene. 2004 Apr 22;23(19):3385-94. doi: 10.1038/sj.onc.1207402. Oncogene. 2004. PMID: 15077184

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,045 results

Search Page